The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Humana has proposed limiting how Medicare Advantage insurance companies can bill the federal government for some diagnoses.

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...

Humana (HUM) backs reforms on extra Medicare Advantage payments from home visits and chart review. Read more here.

DURHAM, N.C. (WTVD) -- The Anaplastology Clinic in Durham doesn't offer typical medical services. Instead, it helps patients ...

Humana beat first-quarter profit and sales estimates as it reduced costs and exited some Medicare Advantage plans.

Health-care companies ticked down as traders weighed the likelihood of changes to the Republican budget bill that would affect the U.S. health system. Humana, the second-biggest Medicare insurer, ...

Humana has entered into a $5 billion unsecured revolving credit agreement with several financial institutions, according to a filing with the Securities and Exchange Commission.

Humana is putting a focus on diversification in its broader strategy around Medicare Advantage bidding, though its legal battle with the feds over the program's star ratings looms as a critical ...

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in ...